DS Investment & Securities Lowers Daewoong Pharmaceutical Target Price to 190,000 Won… Maintains 'Buy' Opinion

DS Investment & Securities lowered Daewoong Pharmaceutical's target price due to a Q1 profitability decline but maintained a 'Buy' rating, considering the issue temporary.

Get the next 8/10 catalyst

Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 51.8%.

Join Telegram channel or scan with phone →